BHEEM M BHAT
Broker in West Chester, PA
License number
Massachusetts 9526977
Issued Date
Apr 22, 2013
Expiration Date
Jul 20, 2017
Type
Salesperson
Address
Address
West Chester, PA 19380
Personal information
See more information about BHEEM M BHAT at radaris.comName
Address
Phone
1214 Mayapple Ln, West Chester, PA 19380
1214 Mayapple Ln, West Chester, PA 19380
Professional information
Bheem Bhat - West Chester, PA
Work:
Independent, Patent/IP reviews, Zintro Inc
Pharmaceutical Consultant Women's Health & Musculoskeletal Biology, Wyeth
Project Team Leader Bone Biology, Osteoporosis, Bio-Assays, Wyeth
Principal Research Scientist II Bone Metabolism, BioAssay, Wyeth - Collegeville, PA
Principal Research Scientist I Molecular Biology/Virology, Wyeth - Radnor, PA
Senior Research Scientist II Biotechnology & Vaccine Dept. Wyeth - Radnor, PA
Research Scientist I
Pharmaceutical Consultant Women's Health & Musculoskeletal Biology, Wyeth
Project Team Leader Bone Biology, Osteoporosis, Bio-Assays, Wyeth
Principal Research Scientist II Bone Metabolism, BioAssay, Wyeth - Collegeville, PA
Principal Research Scientist I Molecular Biology/Virology, Wyeth - Radnor, PA
Senior Research Scientist II Biotechnology & Vaccine Dept. Wyeth - Radnor, PA
Research Scientist I
Education:
St Louis Univ. Medical School - St. Louis, MO
Doctoral in Research Fellowships Washington Univ. School of Medicine - St. Louis, MO
Microbiology & Immunology LH Medical College, Univ. of Delhi - Delhi, Delhi
Ph.D in Medical Microbiology & Epidemiology Mysore Univ - Mysore, Karnataka
M.Sc. in Medical Microbiology St. Aloysius College - Mysore, Karnataka
B Sc in General Science
Doctoral in Research Fellowships Washington Univ. School of Medicine - St. Louis, MO
Microbiology & Immunology LH Medical College, Univ. of Delhi - Delhi, Delhi
Ph.D in Medical Microbiology & Epidemiology Mysore Univ - Mysore, Karnataka
M.Sc. in Medical Microbiology St. Aloysius College - Mysore, Karnataka
B Sc in General Science
Materials And Methods For Identifying Agents That Modulate Norrin, Norrin Mimetics, And Agents Identified Thereby
US Patent:
2007019, Aug 23, 2007
Filed:
Feb 6, 2007
Appl. No.:
11/702613
Inventors:
Frederick Bex - Newtown Square PA, US
Bheem Bhat - West Chester PA, US
Bheem Bhat - West Chester PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
G01N 33/567, C12N 5/06
US Classification:
435007200, 435325000
Abstract:
The specification discloses materials and methods for screening and identifying reagents, which modulate Norrin activity as it relates to Wnt pathway signaling. Preferably, agents identified thereby modulate bone remodeling and/or lipid levels, and can be Norrin mimetics and Norrin agonists, as well as other agonists and mimetics of the LRP5/Norrin/Frizzled4 complex.
Reagents And Method For Modulating Dkk-Mediated Interactions
US Patent:
2007012, Jun 7, 2007
Filed:
Jan 22, 2007
Appl. No.:
11/655924
Inventors:
Kristina Allen - Hopkinton MA, US
Anthony Anisowicz - West Newton MA, US
Veronique Damagnez - Framingham MA, US
John Robinson - Downington PA, US
Paul Yaworsky - Rockland MA, US
Bheem Bhat - West Chester PA, US
Anthony Anisowicz - West Newton MA, US
Veronique Damagnez - Framingham MA, US
John Robinson - Downington PA, US
Paul Yaworsky - Rockland MA, US
Bheem Bhat - West Chester PA, US
International Classification:
C12Q 1/68, G01N 33/53, A61K 39/395, A61K 38/17, C07K 14/705, C07K 16/28, C07H 21/04, C12P 21/06
US Classification:
424143100, 435007100, 514012000, 435006000, 435069100, 435320100, 435325000, 530350000, 530388220, 536023500
Abstract:
The present invention provides reagents, compounds, compositions, and methods relating to novel interactions of the extracellular domain of LRP5, HBM (a variant of LRP5), and/or LRP6 with Dkk, including Dkk-1. The various nucleic acids, polypeptides, antibodies, assay methods, diagnostic methods, and methods of treatment of the present invention are related to and impact on Dkk, LRP5, LRP6, HBM, and Wnt signaling. Dkk, LRP5, LRP6, HBM, and Wnt are implicated in bone and lipid cellular signaling. Thus, the present invention provides reagents and methods for modulating lipid levels and/or bone mass and is useful in the treatment and diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis.
Methods And Materials For Identifying Agents Which Modulate Bone Remodeling And Agents Identified Thereby
US Patent:
2006025, Nov 9, 2006
Filed:
Jun 7, 2004
Appl. No.:
10/559426
Inventors:
John Robinson - Downingtown PA, US
Bheem Bhat - West Chester PA, US
Frederick Bex - Newtown Square PA, US
Bheem Bhat - West Chester PA, US
Frederick Bex - Newtown Square PA, US
International Classification:
C12Q 1/68, A61K 31/404
US Classification:
435006000, 514414000
Abstract:
The invention discloses compositions, compounds, apparatuses and methods of using them to study bone mineralization and identify agents that regulate bone mineralization. Methods of using bone mineralization gene profiles and signatures for compound screening and research are also disclosed. Reagents for modulating bone mineralization are provided for both therapeutic and research usage.